Diabetes, psychotic disorders and antipsychotic therapy: A consensus statement (multiple letters) [5]

Medical Journal of Australia

Volumn 182, Issue 6, 2005, Pages 310-

  Firestone, Andrew ^a   Lambert, Timothy J R ^b   Chapman, Leon H ^c  

^a Royal Melbourne Hospital ^*  (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; CORTICOSTEROID; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE;

ASTHMA; AUSTRALIA; BODY WEIGHT DISORDER; CONSENSUS; DIABETES MELLITUS; DIABETOGENESIS; DYSLIPIDEMIA; HUMAN; LETTER; MEDICAL ETHICS; MEDICAL SOCIETY; METABOLIC DISORDER; PRESCRIPTION; PSYCHOSIS; RISK BENEFIT ANALYSIS; UNITED STATES; WEIGHT GAIN;

EID: 15844370533     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2005.tb06713.x     Document Type: Letter

References (0)